Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidemic Parotitis, Mumps”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01738841
What this trial is testing

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00975507
What this trial is testing

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 480
Not applicableUnknownNCT00932269
What this trial is testing

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

Who this might be right for
DiphtheriaTetanusPertussis+6 more
Swedish Institute for Infectious Disease Control 5,400
Large-scale testing (Phase 3)Study completedNCT00969436
What this trial is testing

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Who this might be right for
VaricellaRubellaMumps+1 more
GlaxoSmithKline 450
Large-scale testing (Phase 3)Study completedNCT00127010
What this trial is testing

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Who this might be right for
MeaslesRubellaMumps+1 more
GlaxoSmithKline
Large-scale testing (Phase 3)Looking for participantsNCT06855160
What this trial is testing

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

Who this might be right for
Chickenpox
GlaxoSmithKline 911
Large-scale testing (Phase 3)Study completedNCT00560755
What this trial is testing

Safety Study of ProQuad® rHA in Infants (V221-037)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 3,388
Not applicableUnknownNCT00645996
What this trial is testing

The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants

Who this might be right for
ImmunityMeaslesMumps+1 more
Assaf-Harofeh Medical Center 100
Post-approval studies (Phase 4)Study completedNCT06331702
What this trial is testing

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Who this might be right for
Japanese EncephalitisMeaslesMumps+1 more
Liaoning Chengda Biotechnology CO., LTD 408
Large-scale testing (Phase 3)Study completedNCT01536405
What this trial is testing

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,412
Large-scale testing (Phase 3)Study completedNCT01188343
What this trial is testing

Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers

Who this might be right for
Japanese EncephalitisMeaslesMumps+1 more
Sanofi Pasteur, a Sanofi Company 542
Post-approval studies (Phase 4)Study completedNCT03160820
What this trial is testing

Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
Centers for Disease Control and Prevention, China 873
Post-approval studies (Phase 4)Not Yet RecruitingNCT06920069
What this trial is testing

Study of Concomitant Administration of the sIPV and DTaP or MMR

Who this might be right for
PolioDiphteria, Tetanus and PertussisMMR Vaccine
Institute of Medical Biology, Chinese Academy of Medical Sciences 2,640
Post-approval studies (Phase 4)Study completedNCT01777529
What this trial is testing

Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations

Who this might be right for
MeaslesMumpsRubella
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 240
Not applicableStudy completedNCT05145166
What this trial is testing

Safety Study of Live Attenuated Mumps Vaccines in Junior High School Students Under 14 Years Old

Who this might be right for
Mumps
Sinovac (Dalian) Vaccine Technology Co., Ltd. 10,000
Post-approval studies (Phase 4)Study completedNCT03368495
What this trial is testing

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Who this might be right for
Vaccine Response Impaired
Alba Maria Ropero 851
Large-scale testing (Phase 3)Study completedNCT01991899
What this trial is testing

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Who this might be right for
MeaslesMumpsRubella+1 more
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,560
Post-approval studies (Phase 4)Study completedNCT00731965
What this trial is testing

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile Rheumatoid
N.M. Wulffraat 140
Large-scale testing (Phase 3)Study completedNCT01621802
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Who this might be right for
Measles-Mumps-Rubella
GlaxoSmithKline 4,011
Large-scale testing (Phase 3)Study completedNCT01681992
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Who this might be right for
MeaslesMumpsRubella+1 more
GlaxoSmithKline 4,538
Next Page